These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24944242)

  • 1. Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise.
    Hew-Butler T; Hummel J; Rider BC; Verbalis JG
    Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R366-75. PubMed ID: 24944242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute changes in arginine vasopressin, sweat, urine and serum sodium concentrations in exercising humans: does a coordinated homeostatic relationship exist?
    Hew-Butler T; Noakes TD; Soldin SJ; Verbalis JG
    Br J Sports Med; 2010 Aug; 44(10):710-5. PubMed ID: 18801773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects.
    Al Therwani S; Mose FH; Jensen JM; Bech JN; Pedersen EB
    BMC Nephrol; 2014 Jun; 15():100. PubMed ID: 24965902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
    Juul KV; Bichet DG; Nielsen S; Nørgaard JP
    Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney collecting duct-derived vasopressin is not essential for appropriate concentration or dilution of urine.
    Zuchowski Y; Carty JS; Trapani JB; Watts JA; Bock F; Zhang M; Terker AS; Zent R; Delpire E; Harris RC; Arroyo JP
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F1091-F1100. PubMed ID: 38695074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.
    Takahashi K; Makita N; Manaka K; Hisano M; Akioka Y; Miura K; Takubo N; Iida A; Ueda N; Hashimoto M; Fujita T; Igarashi T; Sekine T; Iiri T
    J Biol Chem; 2012 Jan; 287(3):2099-106. PubMed ID: 22144672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, pharmacodynamics, and safety of tolvaptan, a nonpeptide AVP antagonist, during ascending single-dose studies in healthy subjects.
    Shoaf SE; Wang Z; Bricmont P; Mallikaarjun S
    J Clin Pharmacol; 2007 Dec; 47(12):1498-507. PubMed ID: 17925589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaptans or voluntary increased hydration to protect the kidney: how do they compare?
    Bankir L; Guerrot D; Bichet DG
    Nephrol Dial Transplant; 2023 Feb; 38(3):562-574. PubMed ID: 34586414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
    Morooka H; Iwanaga Y; Tamaki Y; Takase T; Akahoshi Y; Nakano Y; Fujiki H; Miyazaki S
    Circ Heart Fail; 2012 Jul; 5(4):484-92. PubMed ID: 22628529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of high-intensity intermittent exercise compared with continuous exercise on voluntary water ingestion.
    Mears SA; Shirreffs SM
    Int J Sport Nutr Exerc Metab; 2013 Oct; 23(5):488-97. PubMed ID: 23539667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene.
    Yokoi H; Nagasaki H; Tachikawa K; Arima H; Murase T; Miura Y; Hirabayashi M; Oiso Y
    J Endocrinol; 2002 Apr; 173(1):23-33. PubMed ID: 11927381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise.
    Brown MB; Haack KK; Pollack BP; Millard-Stafford M; McCarty NA
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R605-15. PubMed ID: 21228336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin antagonists: role in the management of hyponatremia.
    Yeates KE; Morton AR
    Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjects.
    Al Therwani S; Rosenbæk JB; Mose FH; Bech JN; Pedersen EB
    BMC Nephrol; 2017 Mar; 18(1):86. PubMed ID: 28288570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preexercise sodium loading aids fluid balance and endurance for women exercising in the heat.
    Sims ST; Rehrer NJ; Bell ML; Cotter JD
    J Appl Physiol (1985); 2007 Aug; 103(2):534-41. PubMed ID: 17463297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin and Vasopressin Antagonists in Heart Failure.
    Vishram-Nielsen JK; Gustafsson F
    Handb Exp Pharmacol; 2017; 243():307-328. PubMed ID: 28432473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
    Gheorghiade M; Niazi I; Ouyang J; Czerwiec F; Kambayashi J; Zampino M; Orlandi C;
    Circulation; 2003 Jun; 107(21):2690-6. PubMed ID: 12742979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ad libitum water consumption prevents exercise-associated hyponatremia and protects against dehydration in soldiers performing a 40-km route-march.
    Nolte HW; Nolte K; Hew-Butler T
    Mil Med Res; 2019 Jan; 6(1):1. PubMed ID: 30678725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 3-day high and low dietary sodium intake on sodium status in response to exertional-heat stress: a double-blind randomized control trial.
    McCubbin AJ; Lopez MB; Cox GR; Caldwell Odgers JN; Costa RJS
    Eur J Appl Physiol; 2019 Sep; 119(9):2105-2118. PubMed ID: 31377851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.